D

Ducentisbio

10 employees

Ducentis is a pre-clinical stage company that aims to develop novel therapies for inflammation and autoimmune disease.

Basic info

Industry

executive offices

Sectors

Biotechnology
Health Care
Medical
Pharmaceutical
Biopharma

Date founded

2015

Funding rounds raised

Total raised

$1.1M

from 3 investors over 3 rounds

D

Ducentisbio raised $1.1M on August 1, 2017

Investors: Capital Cell and Oxford Technology Management

D

Ducentisbio raised $121K on December 14, 2015

Investors: Oxford Technology Management

FAQ